View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Lapatinib 1500 / Fulvestrant 250, Breast Cancer, Cycle 2+
Protocol-ID: 1771 V1.0 (Mini), LAPA1500/FLVS250, Breast Ca, C2+Indication(s)
- Breast Cancer (HR+ postmenopausal, HER2+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 18.04.2021